Evaluation of Microwave Ablation in 4T1 Breast Tumor by a Novel VEFGR2 Targeted Ultrasound Contrast Agents

Evaluation of Microwave Ablation in 4T1 Breast Tumor by a Novel VEFGR2 Targeted Ultrasound Contrast Agents

ObjectivesA novel ultrasound contrast agent (UCA) VEGFR2-targeting iron-doped silica (SiO2) hollow nanoparticles (VEGFR2-PEG-HSNs-Fe NPs) was prepared and applied in microwave ablation for breast cancer to investigate its value in the evaluation of effectiveness after tumor ablation.MethodsVEGFR2-PE...

Full description

Bibliographic Details
Main Authors: Xiaoyu Li, Shujun Xia, Ri Ji, Weiwei Zhan, Wei Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
vascular endothelial growth factor receptor 2 targeted
breast cancer
contrast enhanced ultrasound
ultrasound contrast agent
microwave ablation
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.690152/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.690152/full

Similar Items